PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

First patients receive lab-grown blood vessels from donor cells

2011-06-28
(Press-News.org) For the first time, blood vessels created in the lab from donor skin cells were successfully implanted in patients. Functioning blood vessels that aren't rejected by the immune system could be used to make durable shunts for kidney dialysis, and potentially to improve treatment for children with heart defects and adults needing coronary or other bypass graft surgery.

For the first time, human blood vessels grown in a laboratory from donor skin cells have been successfully implanted into patients, according to new research presented in the American Heart Association's Emerging Science Series webinar.

While more testing is needed, such "off-the-shelf" blood vessels could soon be used to improve the process and affordability of kidney dialysis.

"Our approach could allow hundreds of thousands of patients to be treated from one master cell line," said study lead author Todd N. McAllister, Ph.D., co-founder and chief executive officer of Cytograft Tissue Engineering Inc., of Novato, Calif.

The grafts also have the potential to be used in lower limb bypass to route blood around diseased arteries, to repair congenital heart defects in pediatric patients and to fix damaged arteries in soldiers, who might otherwise lose a limb, said McAllister.

The tissue-engineered blood vessels, produced from sheets of cultured skin cells rolled around temporary support structures, were used to create access shunts between arteries and veins in the arm for kidney dialysis in three patients. These shunts, which connect an artery to a vein, provide access to the blood for dialysis. The engineered vessels were about a foot long with a diameter of 4.8 millimeters.

At follow-up exams up to eight months after implantation, none of the patients had developed an immune reaction to the implants, and the vessels withstood the high pressure and frequent needle punctures required for dialysis. Shunts created from patients' own vessels or synthetic materials are notoriously prone to failure.

Investigators previously showed that using vessels individually created from a patient's own skin cells reduced the rate of shunt complications 2.4-fold over a 3-year period. The availability of off-the-shelf vessels could avoid the expense and months-long process involved in creating custom vessels for each patient, making the technique feasible for widespread use.

Besides addressing a costly and vexing problem in kidney dialysis, off-the-shelf blood vessels might someday be used instead of harvesting patients' own vessels for bypass surgery. A larger, randomized trial of the grafts is under way for kidney dialysis, and human trials have been initiated to assess the safety and effectiveness of these grafts for lower-limb bypass.

The study will be presented in the American Heart Association's Emerging Science Series, which will be held at 1 p.m. EDT/ 12 p.m. CDT. The series is a free online webinar presentation of cutting-edge science. The Emerging Science Series provides a new venue for presenting the latest cardiovascular scientific breakthroughs several times a year, when the discoveries are ready to be presented rather than waiting for a regularly scheduled meeting. Each study is handled in a peer-reviewed process similar to late-breaking clinical trials presented at AHA's annual Scientific Sessions.

The series will include the first presentation of data from clinical trials, basic science, key updates of previously presented trials and major bench-to-bedside breakthroughs. The webinar will be viewable from a computer or mobile phone and attendees can post questions electronically before or after the event. Presentations will be archived for on-demand viewing. For registration and information about the series visit: http://my.americanheart.org/professional/Sessions/AdditionalMeetings/EmergingScienceSeries/New-Emerging-Science-Series_UCM_424613_Article.jsp

INFORMATION:

Co-authors are Wojciech Wystrychowski, M.D.; Lech Cierpka, M.D.; Krzysztof Zagalski, M.D.; Sergio A. Garrido, M.D.; Samuel Radochonski, B.S.; Nathalie Dusserre, Ph.D.; and Nicholas L'Heureux, Ph.D.

Author disclosures are on the abstract. Cytograft funded the study.

Additional Resources:

Kidney Disease and Diabetes
What is Coronary Bypass Surgery?
Care and Treatment for Congenital Heart Defects

Statements and conclusions of study authors published in American Heart Association scientific meetings or presentations are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.

END



ELSE PRESS RELEASES FROM THIS DATE:

False negative tests in breast cancer may lead to wrong drug choice

2011-06-28
A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology. A woman diagnosed with breast cancer can be tested by immunohistochemistry (IHC), a process that detects the presence of specific proteins in cancer tissue. Those who test positive ...

Death rate from heart attack higher in US territories than on mainland

2011-06-28
There is a 17% greater risk of dying after a heart attack if you are treated in a hospital located in a U.S. territory—i.e. the U.S. Virgin Islands, Guam, Puerto Rico, American Samoa, and Northern Mariana Islands—rather than in a hospital in the mainland United States, according to new findings published in the Archives of Internal Medicine. The study by Yale School of Medicine researchers shows that many U.S. citizens who call the U.S. territories home, are at a major healthcare disadvantage. Led by Marcella Nunez-Smith, M.D., assistant professor at Yale School ...

Turan Sahinkaya Joins Board of Directors of ReputationDesigner.com

2011-06-28
TURAN SAHINKAYA has joined the board of directors of ReputationDesigner.com, bringing more than twenty years of experience in the technology industry. Turan Sahinkaya has experience in business technology, telecom, internet and marketing and comes with the opinion that people have the right to control and protect their reputation and privacy. Turan Sahinkaya has worked for some of the world's most recognized industry leaders, as well as several Fortune 100 companies. Turan Sahinkaya is a graduate of University of California at Berkeley with a Bachelor's Degree in ...

Clinical study of epilepsy drug may have been purely promotional

2011-06-28
Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according to a report in the June issue of Archives of Internal Medicine, one of the JAMA/Archives journals. As described in the study by Yale assistant professor of medicine Joseph Ross, M.D., and his colleagues, a seeding trial is a clinical trial conducted primarily for marketing purposes and intended to promote the drug and increase prescribing by exposing ...

Nearly half of women with advanced breast cancer in the US not receiving life-saving treatment

2011-06-28
HOUSTON – Forty-five percent of women with advanced breast cancer in the U.S. did not receive postmastectomy radiation therapy (PMRT) despite the publication of evidence-based guidelines outlining PMRT as a potentially lifesaving treatment, according to new research from The University of Texas MD Anderson Cancer Center. The study, published in the July issue of Cancer, found that PMRT use rates for women with advanced breast cancer have remained static since 1999. According to the research, of the nearly 5,000 women diagnosed with high-risk breast cancer between 1999 ...

Tutors International reassures high profile clients that recent private tutor story regarding Gwyneth Paltrow is untrue as confidentiality is always rigidly upheld

2011-06-28
Tutors International announces that the recent story in the international press claiming that Gwyneth Paltrow and Chris Martin have hired a private tutor from Tutors International to tutor their children is false. The story, reported initially in one of the UK tabloids was quickly spread through the national press and then featured on news networks around the world, naming Tutors International as the chosen private tutoring company, without any of the reporters in question confirming its truth with the company. For more information, visit http://www.tutors-international.com ...

Study: Most parents unaware of teen workplace risks

2011-06-28
Most parents are unaware of the risks their teenagers face in the workplace and could do more to help them understand and prepare for those hazards, according to a new study. Previous findings have shown that about 80 percent of teens are employed during their high school years. But the study from the University of North Carolina at Chapel Hill's Injury Prevention Research Center and North Carolina State University highlights the role parents play in helping their children get those jobs, and making good decisions about workplace safety and health. The paper will be ...

Wildlife surviving conflict in Afghanistan

Wildlife surviving conflict in Afghanistan
2011-06-28
NEW YORK (June 27, 2011) – A new survey conducted by WCS scientists, supported by the U.S. Agency for International Development (USAID), reveals that large mammals, including Asiatic black bears, gray wolves, markhor goats, and leopard cats are surviving in parts of Afghanistan after years of conflict. The field team used camera-trap surveys, transect surveys, and DNA identification of scat samples in the first wildlife update in the conflict-plagued eastern province of Nuristan since 1977. The surveys, conducted between 2006 and 2009 covering an area ...

Precision Mixed Martial Arts - LaGrange NY - MMA Training in Hudson Valley, NY

2011-06-28
Mixed Martial Arts, (MMA), is a combative sport in which competitors use striking, takedowns and submissions to defeat their opponent. MMA can be traces back to many events in Japan and Europe throughout the early 1900s. The modern version of the sport began in the United States in the early 1990s, when the Ultimate Fighting Championship was founded. With the tremendous growth and popularity of the sport has come both the opening of training facilities which offer "Ultimate Fighting" instruction as well as more traditional and established schools changing their ...

Tongue makes the difference in how fish and mammals chew

Tongue makes the difference in how fish and mammals chew
2011-06-28
VIDEO: Brown University evolutionary biologist Nicolai Konow led a team that has teased out the difference in chewing between fish and mammals. Now, the question is where, and with which species,... Click here for more information. PROVIDENCE, R.I. [Brown University] — Evolution has made its mark — large and small — in innumerable patterns of life. New research from Brown University shows chewing has evolved too. Researchers looked at muscles that control the movement ...

LAST 30 PRESS RELEASES:

New perspective highlights urgent need for US physician strike regulations

An eye-opening year of extreme weather and climate

Scientists engineer substrates hostile to bacteria but friendly to cells

New tablet shows promise for the control and elimination of intestinal worms

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston

Depression – discovering faster which treatment will work best for which individual

Breakthrough study reveals unexpected cause of winter ozone pollution

nTIDE January 2025 Jobs Report: Encouraging signs in disability employment: A slow but positive trajectory

Generative AI: Uncovering its environmental and social costs

Lower access to air conditioning may increase need for emergency care for wildfire smoke exposure

Dangerous bacterial biofilms have a natural enemy

Food study launched examining bone health of women 60 years and older

CDC awards $1.25M to engineers retooling mine production and safety

Using AI to uncover hospital patients’ long COVID care needs

$1.9M NIH grant will allow researchers to explore how copper kills bacteria

New fossil discovery sheds light on the early evolution of animal nervous systems

A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior

Study shows how plant roots access deeper soils in search of water

Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs

‘What is that?’ UCalgary scientists explain white patch that appears near northern lights

How many children use Tik Tok against the rules? Most, study finds

Scientists find out why aphasia patients lose the ability to talk about the past and future

Tickling the nerves: Why crime content is popular

Intelligent fight: AI enhances cervical cancer detection

Breakthrough study reveals the secrets behind cordierite’s anomalous thermal expansion

Patient-reported influence of sociopolitical issues on post-Dobbs vasectomy decisions

Radon exposure and gestational diabetes

EMBARGOED UNTIL 1600 GMT, FRIDAY 10 JANUARY 2025: Northumbria space physicist honoured by Royal Astronomical Society

Medicare rules may reduce prescription steering

Red light linked to lowered risk of blood clots

[Press-News.org] First patients receive lab-grown blood vessels from donor cells